Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Net Income: 2024-2025

Historic Net Income for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to -$22.0 million.

  • Pyxis Oncology's Net Income fell 3.77% to -$22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.4 million, marking a year-over-year change of. This contributed to the annual value of -$77.3 million for FY2024, which is 4.66% down from last year.
  • Per Pyxis Oncology's latest filing, its Net Income stood at -$22.0 million for Q3 2025, which was down 3.99% from -$21.2 million recorded in Q2 2025.
  • Pyxis Oncology's 5-year Net Income high stood at -$3.3 million for Q2 2024, and its period low was -$35.6 million during Q4 2024.
  • Over the past 2 years, Pyxis Oncology's median Net Income value was -$21.2 million (recorded in 2024), while the average stood at -$18.4 million.
  • Data for Pyxis Oncology's Net Income shows a maximum YoY slumped of 549.82% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Pyxis Oncology's Net Income stood at -$35.6 million in 2024, then fell by 3.77% to -$22.0 million in 2025.
  • Its Net Income was -$22.0 million in Q3 2025, compared to -$21.2 million in Q2 2025 and -$21.7 million in Q1 2025.